Successful use of rituximab for cutaneous vasculitis

被引：25
作者：
Chung, Lorinda
Funke, Alisa A.
Chakravarty, Eliza F.
Callen, Jeffrey P.
Fiorentino, David F.
机构：
[1] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
[2] Univ Louisville, Sch Med, Louisville, KY 40292 USA
来源：
ARCHIVES OF DERMATOLOGY | 2006年 / 142卷 / 11期
关键词：
D O I：
10.1001/archderm.142.11.1407
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1407 / 1410
页数：4
相关论文
共 24 条
[1]   Use of rituximab in two unusual antibody-mediated autoimmune disorders [J].
Adler, M ;
Soliotis, F ;
Thakrar, S ;
Stratton, R .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2005, 98 (06) :271-272
[2]   Rituximab for autoimmune haemophilia: a proposed treatment algorithm [J].
Aggarwal, A ;
Grewal, R ;
Green, RJ ;
Boggio, L ;
Green, D ;
Weksler, BB ;
Wiestner, A ;
Schechter, GP .
HAEMOPHILIA, 2005, 11 (01) :13-19
[3]   Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus [J].
Arin, MJ ;
Engert, A ;
Krieg, T ;
Hunzelmann, N .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) :620-625
[4]   Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura [J].
Brændstrup, P ;
Bjerrum, OW ;
Nielsen, OJ ;
Jensen, BA ;
Clausen, NT ;
Hansen, PB ;
Andersen, I ;
Schmidt, K ;
Andersen, TM ;
Peterslund, NA ;
Birgens, HS ;
Plesner, T ;
Pedersen, BB ;
Hasselbalch, HC .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) :275-280
[5]   Mechanism of action of rituximab [J].
Cerny, T ;
Borisch, B ;
Introna, M ;
Johnson, P ;
Rose, AL .
ANTI-CANCER DRUGS, 2002, 13 :S3-S10
[6]   Rituximab-induced vasculitis [J].
Dereure, O ;
Navarro, R ;
Rossi, JF ;
Guilhou, JJ .
DERMATOLOGY, 2001, 203 (01) :83-84
[7]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[8]   Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab [J].
Eriksson, P .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (06) :540-548
[9]   Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrom macroglobulinemia does not indicate failure of response [J].
Ghobrial, IM ;
Uslan, DZ ;
Call, TG ;
Witzig, TE ;
Gertz, MA .
AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (04) :329-330
[10]   Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases [J].
Gottenberg, JE ;
Guillevin, L ;
Lambotte, O ;
Combe, B ;
Allanore, Y ;
Cantagrel, A ;
Larroche, C ;
Soubrier, M ;
Bouillet, L ;
Dougados, M ;
Fain, O ;
Farge, D ;
Kyndt, X ;
Lortholary, O ;
Masson, C ;
Moura, B ;
Remy, P ;
Thomas, T ;
Wendling, D ;
Anaya, JM ;
Sibilia, J ;
Mariette, X .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) :913-920
123